Biotechnology > Nova Content
Written by: Alistair J. McIntyre and Eric Furman, Ph.D.
On November 21, 2024, the FDA’s Center for Devices and Radiological... Read More »
Written by: Douglas W. Crandell, Ph.D. and Joseph Mallon, Ph.D.
A recent article[1] authored by Haider J. Warraich, MD[2]; Troy... Read More »
Written by: Kenneth O. Aruda, Ph.D. & Jason J. Jardine
In the ongoing case of Carefirst of Maryland Inc. v. Johnson &... Read More »
Written by: Susan M. Janicki, Ph.D. & Robert J. Hilton, Ph.D.
On October 2, 2024, the U.S. Department of Agriculture (USDA), U.S... Read More »
Written by: Ashley C. Morales & Jane Dai, Ph.D.
On October 7, 2024, the 2024 Nobel Prize in Physiology or Medicine was jointly... Read More »
Written by: Makoto Tsunozaki, Ph.D. & Jason J. Jardine
On August 14, 2024, the U.S. Food and Drug Administration (FDA) approved a... Read More »
Written by: Makoto Tsunozaki, Ph.D. & Jason J. Jardine
On August 14, 2024, the U.S. Food and Drug Administration (FDA) approved a... Read More »
Written by: Alistair J. McIntyre & Agnes Juang, Ph.D.
On August 19, 2024, the Association for Molecular Pathology (AMP) sued the... Read More »
Written by: Rhett D. Ramsey & Joseph Mallon, Ph.D.
Judge Andrews of the District of Delaware recently denied Novartis’s... Read More »
Written by: Susan M. Janicki, Ph.D. & Eric Furman, Ph.D.
On July 10, the Senate unanimously passed the Affordable Prescriptions... Read More »
Written by: Brianne M. Kingery & Michael L. Fuller
On August 13, 2024, the Federal Circuit issued its decision in Allergan USA... Read More »
Written by: Sophia Zahn & Jason J. Jardine
The June 2024 issue of Vanity Fair included the provocative headline: “Why... Read More »
Written by: Ari Feinstein & Jane Dai, Ph.D.
As we previously discussed, on November 7, 2023, the Federal Trade Commission... Read More »
Written by: Susan M. Janicki, Ph.D. & Agnes Juang, Ph.D.
On May 24, 2024, member states of the World Intellectual Property... Read More »
Written by: Ashley C. Morales & Michael L. Fuller
On Friday, June 21, 2024, the FDA updated its Patent Listing Dispute List to... Read More »
Written by: Brianne M. Kingery & Jason J. Jardine
On June 4, 2024, a panel of experts advising the Food and Drug Administration... Read More »
Written by: Alistair J. McIntyre & Eric Furman, Ph.D.
On April 29, 2023, the FDA announced a final rule on regulation of... Read More »
Written by: Brianne M. Kingery & Jason J. Jardine
The Biden Administration’s Inflation Reduction Act (IRA)’s... Read More »
Written by: Ashley C. Morales & Joseph Mallon, Ph.D.
On March 20, 2024, The USPTO issued an alert, notifying practitioners that... Read More »
Written by: Ari Feinstein & Jane Dai, Ph.D.
As we recently discussed, the Federal Trade Commission (“FTC”) sent... Read More »